EP 1841406 A4 20080625 - METHODS AND FORMULATIONS
Title (en)
METHODS AND FORMULATIONS
Title (de)
VERFAHREN UND FORMULIERUNGEN
Title (fr)
PROCEDES ET FORMULATIONS
Publication
Application
Priority
- US 2005046204 W 20051220
- US 63782404 P 20041221
Abstract (en)
[origin: WO2006069079A2] The present invention describes methods and formulations using vitronectin receptor antagonists for the prevention of excessive scarring.
IPC 8 full level
A01N 65/00 (2006.01); A01N 25/00 (2006.01); A61P 17/02 (2006.01)
CPC (source: EP)
A61K 8/4906 (2013.01); A61K 9/0014 (2013.01); A61K 31/55 (2013.01); A61P 17/02 (2017.12); A61P 43/00 (2017.12); A61Q 19/00 (2013.01); A61K 47/10 (2013.01); A61K 47/14 (2013.01); A61K 47/20 (2013.01)
Citation (search report)
- [X] WO 02083125 A1 20021024 - SMITHKLINE BEECHAM CORP [US], et al
- [X] WO 0033838 A1 20000615 - SMITHKLINE BEECHAM CORP [US], et al
- [X] WO 9814192 A1 19980409 - SMITHKLINE BEECHAM CORP [US], et al
- See references of WO 2006069079A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
HR
DOCDB simple family (publication)
WO 2006069079 A2 20060629; WO 2006069079 A3 20070419; AR 052823 A1 20070404; EP 1841406 A2 20071010; EP 1841406 A4 20080625; JP 2008524334 A 20080710; PE 20060870 A1 20060816; TW 200635902 A 20061016
DOCDB simple family (application)
US 2005046204 W 20051220; AR P050105363 A 20051220; EP 05854851 A 20051220; JP 2007548398 A 20051220; PE 2006000024 A 20060103; TW 94145347 A 20051220